AI assistant
Sending…
OptimizeRx Corp — Director's Dealing 2022
Jan 11, 2022
33090_dirs_2022-01-11_3f5a24ad-efbe-40fd-8b94-22c5229cd8e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2022-01-07
Reporting Person: FEBBO WILLIAM J (Director, CHIEF EXECUTIVE OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-01-07 | Common Stock | F | 9627 | — | Acquired | 479004 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-07 | Unvested Restricted Stock Award | $ | F | 9627 | Disposed | 2024-01-07 | Common Stock (28883) | Direct |
Footnotes
F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/3 at the end of each anniversary from issuance.
More from OptimizeRx Corp
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Director's Dealing
2026
Feb 13
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23
Director's Dealing
2025
Dec 23